Compare Indo Euro Indch. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 4.19%
- Poor long term growth as Net Sales has grown by an annual rate of 12.53% and Operating profit at 4.73% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.16
Flat results in Mar 26
Risky - Negative Operating Profits
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 10 Cr (Micro Cap)
33.00
21
0.00%
-0.01
2.66%
0.87
Total Returns (Price + Dividend) 
Indo Euro Indch. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indo Euro Indchem Q4 FY26: Revenue Surge Masks Underlying Operational Weakness
Indo Euro Indchem Limited, a micro-cap specialty chemicals company with a market capitalisation of ₹9.93 crores, reported a net profit of ₹0.06 crores for Q4 FY26 (January-March 2026), representing a modest sequential improvement but continuing a pattern of volatile quarterly performance. The stock traded at ₹10.97 on May 15, down 30.30% over the past year and significantly underperforming both the Sensex and the specialty chemicals sector.
Read full news article
Indo Euro Indchem Ltd Falls to 52-Week Low of Rs.8.01 Amidst Weak Financial Metrics
Indo Euro Indchem Ltd, a micro-cap player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.8.01 today, marking a significant decline amid broader market weakness and sector underperformance.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-May-2026 | Source : BSENewspaper Advertisements
Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Fourth Quarter And Financial Year Ended On March 31 2026
14-May-2026 | Source : BSEFinancial Results for The Fourth Quarter and Financial Year ended on March 31 2026
Submission Of Audited Financial Results For The Financial Year Ended On March 31 2026
14-May-2026 | Source : BSESubmission of Audited Financial Results for the Fourth Quarter and Financial Year ended on March 31 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Vardhman Chhaganlal Shah (26.57%)
Shah Paresh Laxmichand (1.47%)
41.54%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 112.57% vs -48.45% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 175.00% vs -500.00% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 143.33% in Sep 2024
Growth in half year ended Sep 2025 is 4.35% vs 2,200.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -44.29% vs 195.31% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -43.18% vs 2,100.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -1.15% vs 28.37% in Mar 2025
YoY Growth in year ended Mar 2026 is -11.11% vs 800.00% in Mar 2025







